Skip to Content

Real-World Data on Maintenance Avelumab Treatment

The JAVELIN Bladder 100 trial showed a survival benefit for maintenance avelumab following platinum-based chemotherapy in metastatic/locally advanced urothelial carcinoma. This study aimed to provide further insights into real-world outcomes and progression-free survival for patients treated with avelumab, presented in this MEDtalk by Dr. Rehan.

Ahmed Rehan

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top